Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NEXUS AG (GB:0FGL)
LSE:0FGL
Holding GB:0FGL?
Track your performance easily
0FGL Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€44.30 - €61.52
Previous Close€54.32
Volume2.77K
Average Volume (3M)4.02K
Market Cap
€916.38M
Enterprise Value€850.45M
Total Cash (Recent Filing)€110.95M
Total Debt (Recent Filing)€18.67M
Price to Earnings (P/E)36.6
Beta0.43
Next Earnings
Nov 05, 2024EPS Estimate
€0.36Last Dividend Ex-Date
May 16, 2024Dividend Yield0.41%
Share Statistics
EPS (TTM)1.48
Shares OutstandingN/A
10 Day Avg. Volume1,438
30 Day Avg. Volume4,023
Standard Deviation0.08
R-Squared0.12
Alpha0.00996
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€70.00Price Target Upside28.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
NEXUS AG News
Bulls Say, Bears Say
Bulls Say
Growth ProspectsNexus is the fastest-growing Healthcare IT company in the European landscape with numerous growth prospects going forward.
New OrdersSeveral large tender wins, including an extraordinary contract for the German Armed Forces, highlight significant new orders in Germany and abroad.
Revenue GrowthNexus's revenue was up 14.5% year-over-year to €63m.
Bears Say
Earnings2Q24 organic growth of 8.5% was solid but below the 11.8% estimate, and slightly slowing down from previous quarters.
Financial PerformanceEBITDA margin at 19.3% was 15% below expectations, stemming from a lower top line.
Regional PerformancePerformances in Poland, France, and Austria were not as good as in recent quarters.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
19.97% Mutual Funds
0.04% Other Institutional Investors
79.98% Public Companies and
Individual Investors
0FGL FAQ
What was NEXUS AG’s price range in the past 12 months?
NEXUS AG lowest share price was €44.30 and its highest was €61.52 in the past 12 months.
What is NEXUS AG’s market cap?
Currently, no data Available
When is NEXUS AG’s upcoming earnings report date?
NEXUS AG’s upcoming earnings report date is Nov 05, 2024 which is in 40 days.
How were NEXUS AG’s earnings last quarter?
NEXUS AG released its earnings results on Aug 13, 2024. The company reported €0.35 earnings per share for the quarter, beating the consensus estimate of €0.33 by €0.02.
Is NEXUS AG overvalued?
According to Wall Street analysts NEXUS AG’s price is currently Undervalued.
Does NEXUS AG pay dividends?
NEXUS AG pays a Annually dividend of €0.22 which represents an annual dividend yield of 0.41%. See more information on NEXUS AG dividends here
What is NEXUS AG’s EPS estimate?
NEXUS AG’s EPS estimate is €0.36.
How many shares outstanding does NEXUS AG have?
NEXUS AG has 17,262,000 shares outstanding.
What happened to NEXUS AG’s price movement after its last earnings report?
NEXUS AG reported an EPS of €0.35 in its last earnings report, beating expectations of €0.33. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NEXUS AG?
Currently, no hedge funds are holding shares in GB:0FGL
---
NEXUS AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
5.69%
12-Months-Change
Fundamentals
Return on Equity
10.24%
Trailing 12-Months
Asset Growth
12.66%
Trailing 12-Months
Company Description
NEXUS AG
Nexus AG is a software solution provider. It develops, sells and services software solutions for hospitals, specialist clinics and nursing homes. It mainly operates in Germany, Austria, Poland, Switzerland, France, Netherlands and Other regions. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation and social institutions, IT services for IT operation specially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment.
---
0FGL Stock 12 Month Forecast
Average Price Target
€70.00
▲(28.86% Upside)
Technical Analysis
Best Analysts Covering 0FGL
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+17.85%
reiterated a buy rating 7 months ago
Copying Andreas Wolf's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +17.85% per trade.
---